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ABSTRACT 
 
 
Three-dimensional (3D) printing in the domain of congenital 
heart disease (CHD) is still in its infancy. The aim of this 
editorial is to highlight the key findings of a recently published 
systematic review and meta-analysis on the accuracy and 
clinical value of 3D printed heart models (3DPHM). The 
analysis found that 3DPHM can be generated with high 
accuracy and the most reported application of 3DPHM is to 
facilitate pre-operative planning. 
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Introduction 
Three-dimensional (3D) printing has been widely utilized in 
different specialties within the medical field for decades.
1-3
 
However, in the domain of cardiovascular specialties, this 
technology is still considered fairly new.
4
 The conventional 
way to interpret the medical images from two-
dimensional (2D) flat screen lacks comprehensiveness, 
hence tangible 3D printed heart models (3DPHM) were 
created to improve the users’ perception on the depth 
information of the cardiac anatomies.
3-6
 Although there 
are increasing reports on the use of 3DPHM, most of 
them remain anecdotal, and very few of them perform 
quantitative measurements of the accuracy and clinical 
value of the 3DPHM.
4,7
 The relevant questions are: if the 
3DPHM are accurate, to what extent are they accurate; if 
the 3DPHM are useful, in what areas are they useful; and 
do all the studies share the same findings? This editorial 
aims to provide a succinct summary of a recently 
published systematic review and meta-analysis on the 
accuracy and clinical value of 3DPHM.
4 
 
How accurate and useful are the 3D printed heart 
models? 
A total of 24 articles were included in the systematic 
review and 7 of them were used in the meta-analysis.
4
 
Based on the findings of this review, there are 4 different 
imaging modalities that can be used to generate 3DPHM, 
with computed tomography angiography (CTA) being the 
dominant, followed by cardiac magnetic resonance 
(CMR), echocardiography, and rotational angiography. 
Materialise Mimics is the most popular software for 
cardiac image segmentation, with 12 out of 24 studies (50 
per cent) reporting its application.
4
  
 
It was found that the accuracy of the 3DPHM is reported 
in relatively few studies since only 7 out of 24 provided 
the statistical measurements of the 3DPHM.
 
Nevertheless, 
all of these studies shared the same findings: 3DPHM is 
highly accurate. Based on the meta-analysis of 3 eligible 
studies, the pooled mean deviation of 3DPHM 
measurement and original medical images measurement 
is 0.04mm, 95 per cent CI (-0.16, 0.23) (Figure 1), which is 
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considered negligible as it is below the image resolution of 
routine medical CTA and CMR images. This however, needs to 
be interpreted with care as the Cochran’s Q test demonstrates 
high heterogeneity among the studies (p=0.0468).
4
  It is also 
important to note that the quantitative synthesis of 3DPHM 
accuracy did not take into account the 3D printing technique 
and segmentation software used in the individual studies, 
which could also explain the significant heterogeneity among 
the studies. 
 
In terms of the uses of 3DPHM, the most reported use of 
3DPHM is its role in facilitating pre-operative planning, 
followed by medical education, communication, pre-surgical 
simulation, and intra-operative orientation.
4
 Meta-analysis is 
only possible for 4 out of 12 studies which reported the use of 
3DPHM in medical education. It was found that the 3DPHM 
group scored less in the test group compared to the control 
group, although it did not reach statistical significance (-0.43, 
95 per cent CI (-4.75, 3.88), p=0.844) (Figure 2). This finding 
also needs to be interpreted carefully as the Cochran’s Q test 
demonstrates high variations among the studies (p<0.001).
4
 
Although the use of 3DPHM might not improve the students’ 
short-term knowledge on CHD (measured by the test scores), 
the students’ learning experience and satisfaction were 
reported to be improved in all 12 studies.
4
  
 
The 3DPHM were also found to be valuable in helping 
surgeons to decide and define the best surgical approach, 
particularly for complex CHD. 3DPHM also have the potential 
to reduce the operational cost of the surgery due to the 
reduction in surgical duration, however this needs to be 
investigated further with a comprehensive cost-benefit 
analysis.
4
 The role of 3DPHM in improving communication 
within clinical practice is uncertain. Some studies reported 
that the use of 3DPHM can enhance patient-doctor 
interaction, however it does not seem to shorten the 
consultation duration, nor does it increase the short-term 
parental knowledge on CHD. Despite the contradicting results, 
3DPHM is perceived as a complementary tool in patient-
doctor communication, in addition to the original medical 
images.
4
 
 
 
Conclusion 
Based on the results from this systematic review and meta-
analysis, it can be concluded that there is a paucity of 
comprehensive and systematic studies about 3D printing of 
CHD in the current literature. Although 3D printing of CHD is 
still considered at its early development stage, the results 
from current studies are promising. 3DPHM can be fabricated 
with high accuracy, and multiple groups of stakeholders can 
benefit from the application of this technology in the 
diagnosis and treatment of CHD. However, more studies 
based on larger sample sizes are required to validate 
these positive findings. Future studies should also focus 
on investigating the cost-benefit of implementing 3D 
printing technology in the domain of CHD before it is 
incorporated into a routine diagnostic approach. 
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Figure 1: Forest plot for mean bias of the 3DPHM 
measurement and the digital images measurement. 3D, 
three-dimensional; B-A, Bland-Altman; MRAW, raw mean 
difference; CI, confidence interval; SE, standard error. 
Reprinted with permission under the open access from Lau 
and Sun.
4
 
 
 
 
Figure 2: Forest plot for mean differences in test scores 
between the 3DPHM and the control groups. 3D, three-
dimensional; CI, confidence interval; MD, mean difference; 
SD, standard deviation; SE, standard error. Reprinted with 
permission under the open access from Lau and Sun.
4
 
 
 
 
